litlas
Log inCreate account

Wolfgang Kern

Active 1990–2025

185
Papers
27,758
Citations
97
h-index
176
i10-index

Citations

Citations per year for Wolfgang Kern1986: 1 citations1992: 1 citations1993: 1 citations1994: 4 citations1995: 1 citations1996: 1 citations1997: 4 citations1998: 1 citations1999: 8 citations2000: 12 citations2001: 25 citations2002: 25 citations2003: 76 citations2004: 96 citations2005: 161 citations2006: 131 citations2007: 204 citations2008: 208 citations2009: 189 citations2010: 214 citations2011: 245 citations2012: 255 citations2013: 257 citations2014: 298 citations2015: 226 citations2016: 260 citations2017: 215 citations2018: 211 citations2019: 797 citations2020: 764 citations2021: 700 citations2022: 640 citations2023: 574 citations2024: 713 citations2025: 312 citations2026: 7 citations1987–1991: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,444 citing papers, 25.2% of this breakdownGermany: 1,085 citing papers, 11.2% of this breakdownUnited Kingdom: 649 citing papers, 6.7% of this breakdownItaly: 620 citing papers, 6.4% of this breakdownFrance: 532 citing papers, 5.5% of this breakdownChina: 476 citing papers, 4.9% of this breakdownSpain: 363 citing papers, 3.7% of this breakdownNetherlands: 347 citing papers, 3.6% of this breakdownJapan: 283 citing papers, 2.9% of this breakdownCanada: 273 citing papers, 2.8% of this breakdownAustralia: 234 citing papers, 2.4% of this breakdownSweden: 214 citing papers, 2.2% of this breakdown
0%25.2%Other 22.5%

Institutions

Fields

  • Medicine76.1%
  • Biochemistry, Genetics and Molecular Biology16.1%
  • Immunology and Microbiology2.5%
  • Neuroscience2%
  • Computer Science1.2%
  • Psychology0.5%
  • Other1.6%

Topics

  • Acute Myeloid Leukemia Research19.7%
  • Myeloproliferative Neoplasms: Diagnosis and Treatment5.5%
  • Acute Lymphoblastic Leukemia research5%
  • Chronic Myeloid Leukemia Treatments4.4%
  • Chronic Lymphocytic Leukemia Research3.8%
  • Hematopoietic Stem Cell Transplantation3.5%
  • Other58.1%

Coauthors

All papers

Open in search
  1. 2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party

    Authors: Michael Heuser, Sylvie Freeman, Gert J. Ossenkoppele, Francesco Buccisano, Christopher S. Hourigan, Lok Lam Ngai, Jesse M. Tettero, Costa Bachas, Constance Baer, Marie C. Béné, Veit Bücklein, Anna Czyż, Barbara Denys, Richard Dillon, Michaela Feuring‐Buske, Mónica L. Guzmán, Torsten Haferlach, Lina Han, Julia Herzig, Jeffrey L. Jorgensen, Wolfgang Kern, Marina Konopleva, Francis Lacombe, Marta Libura, Agata Majchrzak, Luca Maurillo, Yishai Ofran, Jan Philippé, Adriana Pleșa, Claude Preudhomme, Farhad Ravandi, Christophe Roumier, Marion Subklewe, Felicitas Thol, Arjan A. van de Loosdrecht, Bert A. van der Reijden, Adriano Venditti, Agnieszka Wierzbowska, Peter J.M. Valk, Brent L. Wood, Roland B. Walter, Christian Thiede, Konstanze Döhner, Gail J. Roboz, Jacqueline Cloos - Blood 2021 cited by 718

  2. Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party

    Authors: Gerrit Jan Schuurhuis, Michael Heuser, Sylvie Freeman, Marie C. Béné, Francesco Buccisano, Jacqueline Cloos, David Grimwade, Torsten Haferlach, Robert K. Hills, Christopher S. Hourigan, Jeffrey L. Jorgensen, Wolfgang Kern, Francis Lacombe, Luca Maurillo, Claude Preudhomme, Bert A. van der Reijden, Christian Thiede, Adriano Venditti, Paresh Vyas, Brent L. Wood, Roland B. Walter, Konstanze Döhner, Gail J. Roboz, Gert J. Ossenkoppele - Blood 2018 cited by 1,029

  3. Landscape Of Genetic Lesions In 944 Patients With Myelodysplastic Syndromes

    Authors: Torsten Haferlach, Yasunobu Nagata, Vera Grossmann, Yusuke Okuno, Ulrike Bacher, Genta Nagae, Susanne Schnittger, Masashi Sanada, Ayana Kon, Tamara Alpermann, Kenichi Yoshida, Andreas Roller, Niroshan Nadarajah, Yuichi Shiraishi, Yusuke Shiozawa, Kenichi Chiba, Hiroko Tanaka, H. Phillip Koeffler, H-U Klein, Martin Dugas, Hiroyuki Aburatani, Alexander Kohlmann, Satoru Miyano, Claudia Haferlach, Wolfgang Kern, Seishi Ogawa - Blood 2013 cited by 1,524

  4. Enhancer Hijacking Drives Oncogenic BCL11B Expression in Lineage-Ambiguous Stem Cell Leukemia

    Authors: Lindsey E. Montefiori, Sonja Bendig, Zhaohui Gu, Xiaolong Chen, Petri Pölönen, Xiaotu Ma, Alex Murison, Andy G.X. Zeng, Laura García‐Prat, Kirsten Dickerson, Ilaria Iacobucci, Sherif Abdelhamed, Ryan Hiltenbrand, Paul E. Mead, Cyrus M. Mehr, Beisi Xu, Zhongshan Cheng, Ti‐Cheng Chang, Tamara Westover, Jing Ma, Anna Stengel, Shunsuke Kimura, Chunxu Qu, Marcus B. Valentine, Marissa Rashkovan, Selina M. Luger, Mark R. Litzow, Jacob M. Rowe, Monique L. den Boer, Victoria Wang, Jun Yin, Steven M. Kornblau, Stephen P. Hunger, Mignon L. Loh, Ching‐Hon Pui, Wenjian Yang, Kristine R. Crews, Kathryn G. Roberts, Jun J. Yang, Mary V. Relling, William E. Evans, Wendy Stock, Elisabeth Paietta, Adolfo A. Ferrando, Jinghui Zhang, Wolfgang Kern, Torsten Haferlach, Gang Wu, John E. Dick, Jeffery M. Klco, Claudia Haferlach, Charles G. Mullighan - Cancer Discovery 2021 cited by 188

  5. TP53 mutation status divides myelodysplastic syndromes with complex karyotypes into distinct prognostic subgroups

    Authors: Detlef Haase, Kristen E. Stevenson, Donna Neuberg, Jaroslaw P. Maciejewski, Aziz Nazha, Mikkael A. Sekeres, Benjamin L. Ebert, Guillermo Garcia‐Manero, Claudia Haferlach, Torsten Haferlach, Wolfgang Kern, Seishi Ogawa, Yasunobu Nagata, Kenichi Yoshida, Timothy A. Graubert, Matthew J. Walter, Alan F. List, Rami S. Komrokji, Eric Padron, David A. Sallman, Elli Papaemmanuil, Peter J. Campbell, Michael R. Savona, Adam C. Seegmiller, Lionel Adès, Pierre Fenaux, Lee‐Yung Shih, David Bowen, Michael J. Groves, Sudhir Tauro, Michaëla Fontenay, Olivier Kosmider, Michal Bar‐Natan, David P. Steensma, Richard M. Stone, Michael Heuser, Felicitas Thol, Mario Cazzola, Luca Malcovati, Aly Karsan, Christina Ganster, Eva Hellström‐Lindberg, Jacqueline Boultwood, Andrea Pellagatti, Valeria Santini, Lynn Quek, Paresh Vyas, Heinz Tüchler, Peter L. Greenberg, Rafael Bejar - Leukemia 2019 cited by 259

  6. BRAF Mutations in Hairy-Cell Leukemia

    Authors: Enrico Tiacci, Владимир Трифонов, Gianluca Schiavoni, Antony B. Holmes, Wolfgang Kern, Maria Paola Martelli, Alessandra Pucciarini, Barbara Bigerna, Roberta Pacini, Victoria A. Wells, Paolo Sportoletti, Valentina Pettirossi, Roberta Mannucci, Oliver Elliott, Arcangelo Liso, Achille Ambrosetti, Alessandro Pulsoni, Francesco Forconi, Livio Trentin, Gianpietro Semenzato, Giorgio Inghirami, Monia Capponi, Francesco Di Raimondo, Caterina Patti, Luca Arcaini, Pellegrino Musto, Stefano Pileri, Claudia Haferlach, Susanne Schnittger, Giovanni Pizzolo, Robin Foà, Laurent Farinelli, Torsten Haferlach, Laura Pasqualucci, Raúl Rabadán, Brunangelo Falini - New England Journal of Medicine 2011 cited by 1,019

  7. Genetic abnormalities in myelodysplasia and secondary acute myeloid leukemia: impact on outcome of stem cell transplantation

    Authors: Tetsuichi Yoshizato, Yasuhito Nannya, Yoshiko Atsuta, Yusuke Shiozawa, Yuka Iijima‐Yamashita, Kenichi Yoshida, Yuichi Shiraishi, Hiromichi Suzuki, Yasunobu Nagata, Yusuke Sato, Nobuyuki Kakiuchi, Keitaro Matsuo, Makoto Onizuka, Keisuke Kataoka, Kenichi Chiba, Hiroko Tanaka, Hiroo Ueno, Masahiro Nakagawa, Bartlomiej Przychodzen, Claudia Haferlach, Wolfgang Kern, Kosuke Aoki, Hidehiro Itonaga, Yoshinobu Kanda, Mikkael A. Sekeres, Jaroslaw P. Maciejewski, Torsten Haferlach, Yasushi Miyazaki, Keizo Horibe, Masashi Sanada, Satoru Miyano, Hideki Makishima, Seishi Ogawa - Blood 2017 cited by 352

  8. Classification and Personalized Prognostic Assessment on the Basis of Clinical and Genomic Features in Myelodysplastic Syndromes

    Authors: Matteo Bersanelli, Erica Travaglino, Manja Meggendorfer, Tommaso Matteuzzi, Claudia Sala, Ettore Mosca, Chiara Chiereghin, Noemi Di Nanni, Matteo Gnocchi, Matteo Zampini, Marianna Rossi, Giulia Maggioni, Alberto Termanini, Emanuele Angelucci, Massimo Bernardi, Lorenza Borin, Benedetto Bruno, Francesca Bonifazi, Valeria Santini, Andrea Bacigalupo, Maria Teresa Voso, Esther Natalie Olíva, Marta Riva, Marta Ubezio, Lucio Morabito, Alessia Campagna, Claudia Saitta, Victor Savevski, Enrico Giampieri, Daniel Remondini, Francesco Passamonti, Fabio Ciceri, Niccolò Bolli, Alessandro Rambaldi, Wolfgang Kern, Shahram Kordasti, Françesc Solé, Laura Palomo, Guillermo Sanz, Armando Santoro, Uwe Platzbecker, Pierre Fenaux, Luciano Milanesi, Torsten Haferlach, Gastone Castellani, Matteo Giovanni Della Porta - Journal of Clinical Oncology 2021 cited by 225

  9. AML classification in the year 2023: How to avoid a Babylonian confusion of languages

    Authors: Sandra Huber, Constance Baer, Stephan Hütter, Frank Dicker, Manja Meggendorfer, Christian Pohlkamp, Wolfgang Kern, Torsten Haferlach, Claudia Haferlach, Gregor Hoermann - Leukemia 2023 cited by 67

  10. Artificial intelligence in hematological diagnostics: Game changer or gadget?

    Authors: Wencke Walter, Christian Pohlkamp, Manja Meggendorfer, Niroshan Nadarajah, Wolfgang Kern, Claudia Haferlach, Torsten Haferlach - Blood Reviews 2022 cited by 79

  11. Dynamics of clonal evolution in myelodysplastic syndromes

    Authors: Hideki Makishima, Tetsuichi Yoshizato, Kenichi Yoshida, Mikkael A. Sekeres, Tomas Radivoyevitch, Hiromichi Suzuki, B Przychodzen, Yasunobu Nagata, Manja Meggendorfer, Masashi Sanada, Yusuke Okuno, Cassandra M. Hirsch, Teodora Kuzmanovic, Yusuke Sato, Aiko Sato‐Otsubo, Thomas LaFramboise, Naoko Hosono, Yuichi Shiraishi, Kenichi Chiba, Claudia Haferlach, Wolfgang Kern, Hiroko Tanaka, Yusuke Shiozawa, Inés Gómez‐Seguí, Holleh Husseinzadeh, Swapna Thota, Kathryn M Guinta, Brittney Dienes, Tsuyoshi Nakamaki, Shuichi Miyawaki, Yogen Saunthararajah, Shigeru Chiba, Satoru Miyano, Lee‐Yung Shih, Torsten Haferlach, Seishi Ogawa, Jaroslaw P. Maciejewski - Nature Genetics 2016 cited by 423

  12. Real-World Validation of Molecular International Prognostic Scoring System for Myelodysplastic Syndromes

    Authors: Elisabetta Sauta, Marie Robin, Matteo Bersanelli, Erica Travaglino, Manja Meggendorfer, Lin‐Pierre Zhao, Juan Carlos Caballero Berrocal, Claudia Sala, Giulia Maggioni, Massimo Bernardi, Carmen Di Grazia, Luca Vago, Giulia Rivoli, Lorenza Borin, Saverio D’Amico, Cristina Astrid Tentori, Marta Ubezio, Alessia Campagna, Antonio Russo, Daniele Mannina, Luca Lanino, Patrizia Chiusolo, Luisa Giaccone, Maria Teresa Voso, Marta Riva, Esther Natalie Olíva, Matteo Zampini, Elena Riva, Olivier Nibourel, Marilena Bicchieri, Niccolò Bolli, Alessandro Rambaldi, Francesco Passamonti, Victor Savevski, Armando Santoro, Ulrich Germing, Shahram Kordasti, Valeria Santini, María Díez‐Campelo, Guillermo Sanz, Françesc Solé, Wolfgang Kern, Uwe Platzbecker, Lionel Adès, Pierre Fenaux, Torsten Haferlach, Gastone Castellani, Matteo Giovanni Della Porta - Journal of Clinical Oncology 2023 cited by 111

  13. Technical Aspects of Flow Cytometry-based Measurable Residual Disease Quantification in Acute Myeloid Leukemia: Experience of the European LeukemiaNet MRD Working Party

    Authors: Jesse M. Tettero, Sylvie Freeman, Veit Buecklein, Adriano Venditti, Luca Maurillo, Wolfgang Kern, Roland B. Walter, Brent L. Wood, Christophe Roumier, Jan Philippé, Barbara Denys, Jeffrey L. Jorgensen, Marie C. Bene, Francis Lacombe, Adriana Plesa, Monica L. Guzman, Agnieszka Wierzbowska, Anna Czyz, Lok Lam Ngai, Adrian Schwarzer, Costa Bachas, Jacqueline Cloos, Marion Subklewe, Michaela Fuering-Buske, Francesco Buccisano - HemaSphere 2021 cited by 84

  14. Novel causative variants of VEXAS in UBA1 detected through whole genome transcriptome sequencing in a large cohort of hematological malignancies

    Authors: Maki Sakuma, Piers Blombery, Manja Meggendorfer, Claudia Haferlach, Markus Lindauer, Uwe M. Martens, Wolfgang Kern, Torsten Haferlach, Wencke Walter - Leukemia 2023 cited by 62

  15. How artificial intelligence might disrupt diagnostics in hematology in the near future

    Authors: Wencke Walter, Claudia Haferlach, Niroshan Nadarajah, Ines Schmidts, Constanze Kühn, Wolfgang Kern, Torsten Haferlach - Oncogene 2021 cited by 76

  16. Hematologist‐Level Classification of Mature B‐Cell Neoplasm Using Deep Learning on Multiparameter Flow Cytometry Data

    Authors: Max Zhao, Nanditha Mallesh, Alexander Höllein, Richard Schabath, Claudia Haferlach, Torsten Haferlach, F. Elsner, Hannes Lüling, Peter Krawitz, Wolfgang Kern - Cytometry Part A 2020 cited by 60

  17. Prognostic relevance of FLT3-TKD mutations in AML: the combination matters—an analysis of 3082 patients

    Authors: Ulrike Bacher, Claudia Haferlach, Wolfgang Kern, Torsten Haferlach, Susanne Schnittger - Blood 2007 cited by 411

  18. Reproducible diagnosis of chronic lymphocytic leukemia by flow cytometry: An European Research Initiative on CLL (ERIC) & European Society for Clinical Cell Analysis (ESCCA) Harmonisation project

    Authors: Andy C. Rawstron, Karl‐Anton Kreuzer, Asha Soosapilla, Martin Špaček, Olga Stehlíková, Peter Gambell, Neil McIver‐Brown, Neus Villamor, Katherina Psarra, Maria Arroz, Raffaella Milani, Javier de la Serna, María‐Teresa Cedena, Ozren Jakšić, Josep Nomdedéu, Carol Moreno, Gian Matteo Rigolin, Antonio Cuneo, Preben Johansen, Hans Erik Johnsen, Richard Rosenquist, Carsten Utoft Niemann, Wolfgang Kern, David Westerman, Marek Trněný, Stephen P. Mulligan, Michael Doubek, Šárka Pospı́šilová, Peter Hillmen, David Oscier, Michael Hallek, Paolo Ghia, Emili Montserrat - Cytometry Part B Clinical Cytometry 2017 cited by 198

  19. Interplay of TP53 allelic state, blast count, and complex karyotype on survival of patients with AML and MDS

    Authors: Anna Stengel, Manja Meggendorfer, Wencke Walter, Constance Baer, Niroshan Nadarajah, Stephan Hütter, Wolfgang Kern, Torsten Haferlach, Claudia Haferlach - Blood Advances 2023 cited by 46

  20. The impact of TP53 mutations and TP53 deletions on survival varies between AML, ALL, MDS and CLL: an analysis of 3307 cases

    Authors: Anna Stengel, Wolfgang Kern, Torsten Haferlach, Manja Meggendorfer, Annette Fasan, Claudia Haferlach - Leukemia 2016 cited by 236

  21. TP53 mutations occur in 15.7% of ALL and are associated with MYC-rearrangement, low hypodiploidy, and a poor prognosis

    Authors: Anna Stengel, Susanne Schnittger, Sandra Weißmann, Sabrina Kuznia, Wolfgang Kern, Alexander Kohlmann, Torsten Haferlach, Claudia Haferlach - Blood 2014 cited by 170

  22. Mutational patterns and their correlation to CHIP-related mutations and age in hematological malignancies

    Authors: Anna Stengel, Constance Baer, Wencke Walter, Manja Meggendorfer, Wolfgang Kern, Torsten Haferlach, Claudia Haferlach - Blood Advances 2021 cited by 63

  23. Landscape of TET2 mutations in acute myeloid leukemia

    Authors: Sandra Weißmann, Tamara Alpermann, Vera Grossmann, Andreas Kowarsch, Niroshan Nadarajah, Christiane Eder, Frank Dicker, Annette Fasan, Claudia Haferlach, Torsten Haferlach, Wolfgang Kern, Susanne Schnittger, Alexander Kohlmann - Leukemia 2011 cited by 259

  24. AML with 11q23/MLL abnormalities as defined by the WHO classification: incidence, partner chromosomes, FAB subtype, age distribution, and prognostic impact in an unselected series of 1897 cytogenetically analyzed AML cases

    Authors: Claudia Schoch, Susanne Schnittger, Mirjam Klaus, Wolfgang Kern, Wolfgang Hiddemann, Torsten Haferlach - Blood 2003 cited by 353